Literature DB >> 11115458

New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment.

S Z Goldhaber1, K Dunn, R C MacDougall.   

Abstract

CONTEXT: Guidelines to prevent venous thromboembolism (VTE) have been widely distributed and generally have been assumed to be effective. Therefore, among hospitalized patients, the development of VTE is thought to occur in the context of omitted prophylaxis.
OBJECTIVES: To describe hospitalized patients who develop VTE and to determine whether they received antecedent prophylaxis.
DESIGN: Case series.
SETTING: Brigham and Women's Hospital. PATIENTS: Three hundred eighty-four patients who developed in-hospital deep venous thrombosis or pulmonary embolism or who developed VTE within 30 days of prior hospital discharge. MAIN OUTCOME MEASURES: The relationship of developing new-onset VTE to the use or omission of antecedent in-hospital prophylaxis.
RESULTS: Of the 384 identified patients, 272 had deep venous thrombosis alone, 62 had pulmonary embolism alone, and 50 had deep venous thrombosis and pulmonary embolism. Most were medical service patients; fewer than one fourth were general or orthopedic surgery patients. Overall, 52% had received antecedent VTE prophylaxis. Thirteen deaths (3.4%) were ascribed to pulmonary embolism, and prophylaxis was omitted in only 1 of those 13 patients.
CONCLUSIONS: Most deaths from pulmonary embolism among patients hospitalized for other conditions occurred in the setting of failed prophylaxis rather than omitted prophylaxis. High-risk patients, especially medical service patients, warrant intensive VTE prophylaxis and close follow-up to ensure successful outcomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115458     DOI: 10.1378/chest.118.6.1680

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Robin Offord; Adam C Lloyd; Pippa Anderson; Andy Bearne
Journal:  Pharm World Sci       Date:  2004-08

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Risk factors of acute pulmonary thromboembolism in Japanese patients hospitalized for medical illness: results of a multicenter registry in the Japanese society of pulmonary embolism research.

Authors:  Mashio Nakamura; Masahito Sakuma; Norikazu Yamada; Nobuhiro Tanabe; Norifumi Nakanishi; Yoshiyuki Miyahara; Takayuki Kuriyama; Takeyoshi Kunieda; Kunio Shirato; Tsuneaki Sugimoto; Takeshi Nakano
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 4.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 5.  A systematic review of Cochrane anticoagulation reviews.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2009-01-06

6.  Venous thromboembolism prophylaxis among medical patients at US hospitals.

Authors:  Michael B Rothberg; Maureen Lahti; Penelope S Pekow; Peter K Lindenauer
Journal:  J Gen Intern Med       Date:  2010-03-30       Impact factor: 5.128

7.  [Thrombosis prophylaxis in geriatric patients].

Authors:  R E Roller; P Feichtinger
Journal:  Z Gerontol Geriatr       Date:  2012-04       Impact factor: 1.281

8.  Venous thromboembolism (VTE) in hospitalized cancer patients: prophylaxis failure or failure to prophylax!

Authors:  Hikmat Abdel-Razeq; Faisal Albadainah; Shadi Hijjawi; Asem Mansour; Imad Treish
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

9.  Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.

Authors:  Andrea J Darzi; Samer G Karam; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Mary Cushman; Michael K Gould; Lawrence Mbuagbaw; Frederick A Spencer; Alex C Spyropoulos; Michael B Streiff; Scott Woller; Neil A Zakai; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

Review 10.  Prevention of venous thromboembolism in hospitalized patients with cancer.

Authors:  Charles W Francis
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.